Skip to content

Welcome to Discover Pharma! Today is : November 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

allergy treatment

  • Research & Development,Therapeutic Areas

    Aravax reports positive Phase 2 results for peanut allergy immunotherapy

    Aravax’s PVX108 immunotherapy met its primary endpoint in a Phase [...]

    November 13, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Aravax to present Phase 2 peanut allergy data in November

    Aravax will present topline Phase 2 clinical trial results for [...]

    October 5, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Therapeutic Areas

    EURneffy recommended for emergency anaphylaxis treatment in NHS Wales

    ALK’s 2mg nasal adrenaline spray has been recommended for use [...]

    September 16, 2026
  • Clinical & Regulatory

    Acarizax accepted for house dust mite allergy treatment in NHS Scotland

    Acarizax has been accepted for use in NHS Scotland for [...]

    August 11, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neurizon advances NUZ-001 ALS trial into treatment extension
    Categories: Clinical & Regulatory
  • ViiV HIV medicines receive positive EU opinion for younger children
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ofichem agrees to acquire US CDMO Kinentia Biosciences
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top